Warrant Inducement Agreement - PMGC Holdings Inc has entered into a warrant inducement agreement with existing institutional investors for the exercise of certain outstanding Series A warrants [1] - The investors agreed to exercise the outstanding warrants to purchase 969,385 shares of the company's common stock at an amended exercise price of 1 9 million [1] - The closing of the warrant inducement transactions is expected to occur on or about January 28, 2025 [2] New Warrants Issuance - In consideration for the exercise of the warrants, the company agreed to issue new warrants to purchase an aggregate of 969,385 shares of common stock with an exercise price of $2 75 per share [3] - The new warrants are exercisable upon shareholder approval and will expire five years from the date of shareholder approval [3] - The company has agreed to file a registration statement within 30 days with the SEC covering the resale of the shares issuable upon exercise of the new warrants [3] Company Overview - PMGC Holdings Inc is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries [5] - The company's portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc, PMGC Research Inc, and PMGC Capital LLC [5]
PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors